Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Prostatic Neoplasms × dexamethasone acetate × 90 days × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Multiple Myeloma 14 Burkitt Lymphoma 7 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4 Neoplasm Metastasis 3 Leukemia, Biphenotypic, Acute 3 Recurrence 2 Neoplasms 2 Smoldering Multiple Myeloma 1 Prostatic Neoplasms 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Plasmacytoma 1 Myelodysplastic Syndromes 1 Meningioma 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1 Leukemia, Myelomonocytic, Chronic 1 Immunoglobulin Light-chain Amyloidosis 1 Hodgkin Disease 1 Fatigue 1 Down Syndrome 1 Brain Neoplasms 1 Blastic Plasmacytoid Dendritic Cell Neoplasm 1 Ann Arbor Stage II Mantle Cell Lymphoma 1

Interventions

Specimen Handling 48 Magnetic Resonance Spectroscopy 48 enzalutamide 43 Prednisone 36 apalutamide 33 Androgen Antagonists 32 Abiraterone Acetate 32 Leuprolide 27 darolutamide 25 Radiotherapy 23 Docetaxel 22 Radiosurgery 21 abiraterone 20 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 18 Biopsy 17 relugolix 16 Goserelin 16 cabazitaxel 14 X-Rays 14 Radiation 14 Pluvicto 14 Triptorelin Pamoate 13 luprolide acetate gel depot 12 bicalutamide 12 prednylidene 11 deltacortene 11 Gonadotropin-Releasing Hormone 11 Glutamate Carboxypeptidase II 11 Carboplatin 11 gallium 68 PSMA-11 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06136598 2026-02-17

MK-5684-001

Merck Sharp & Dohme LLC

Phase 1 Active not recruiting

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡